サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463827

抗体探索の市場規模・動向、世界・地域シェア、動向、成長機会分析レポート：抗体タイプ別、性質別、サービス別、エンドユーザー別、地域別

Antibody Discovery Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Antibody Type, Nature, Service, End User, and Geography
出版日: | 発行: The Insight Partners | ページ情報: 英文 180 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
抗体探索の市場規模・動向、世界・地域シェア、動向、成長機会分析レポート：抗体タイプ別、性質別、サービス別、エンドユーザー別、地域別
出版日: 2024年02月27日
発行: The Insight Partners
ページ情報: 英文 180 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

抗体探索の市場規模は、2022年の29億4,000万米ドルから2030年には49億2,000万米ドルに急増すると予測されており、2022年から2030年のCAGRは6.7%を記録すると予測されています。研究開発への投資の増加とがん罹患率の上昇が抗体探索市場の成長を後押ししています。

生物製剤に重点を置くバイオ医薬品産業の拡大により、抗体研究サービスに対する需要は以前よりも高まっています。業界関係者と学術機関との協力関係の強化は、リソースの共有と抗体探索の加速を促進します。個別化医療や患者の嗜好を重視した患者中心の医薬品開発へのシフトが抗体探索市場を後押ししています。

ハイスループット・スクリーニング、ファージ・ディスプレイ、次世代シーケンシングなどの継続的な技術進歩により、抗体探索プロセスの効率とスピードが向上しています。また、政府機関や非公開会社による研究開発活動への資金提供の増加も、抗体探索の取り組みに拍車をかけています。モノクローナル抗体は、特定の抗原を標的とする特異性と有効性により、治療用途で人気を集めており、その結果、抗体研究サービスへの需要が増加しています。したがって、抗体ベースの治療に対する需要の高まりとアウトソーシング志向は、今後数年間の抗体探索市場予測に大きな影響を与えると考えられます。

がん罹患率の上昇が抗体探索市場を牽引

2020年に発表されたGlobal Cancer Observatory（GLOBOCAN）の推計によると、世界中で1,930万人のがん患者が発生しています。症例数は米国、中国、インドで著しく多いです。GLOBOCANはさらに、インドのがん患者は2040年までに208万人に達し、2020年から57.5％増加すると推定しています。同様に、2022年2月に発表された世界保健機関（WHO）のデータでは、世界中で1,000万人ががんで死亡しています。米国がん協会の報告書によると、2019年1月以降、米国にはがんの既往歴がある人が～1690万人居住しています。2030年1月までに、がんサバイバーの人口は2,210万人に達すると推定されており、これは主に人口の高齢化と関連づけることができます。肺がん、乳がん、大腸がん、前立腺がん、乳房がんなどが、最も多く報告されているがんの種類です。がん罹患率の増加は、世界中で懸念を呼んでいます。以下は、2020年に世界で報告される一般的ながん症例のリストです。

  • 表1.2020年における世界の新規がん患者数

番号がんの種類罹患数（百万人）

1胃1.09

2皮膚（非黒色腫）1.2

3前立腺1.41

4大腸・直腸1.93

5肺2.21

6乳房2.26

出典世界保健機関、2020年2月

がんは現在、不健康な食習慣や運動不足の人によく見られる生活習慣病です。アルコールやタバコを頻繁に摂取することも、この疾患の発症リスクを高めています。中低所得国における慢性感染症は、がんの危険因子をさらに悪化させる。がん罹患率の増加は、革新的ながん治療の必要性を示しています。モノクローナル抗体は、がん細胞の活性を抑制し、がん細胞を排除する免疫系の自然な能力を高める、有望な標的抗がん剤の一種です。抗体薬物複合体（ADC）もまた、がん治療において有望な結果を示しています。さらに、現代のバイオテクノロジーの進歩により、研究者や企業は優れた設計の新規抗体を提供できるようになり、さまざまな種類のがんの治療成功への道が開かれました。このように、さまざまな種類のがんの急増が抗体探索市場の成長を後押ししています。

市場動向

カスタム抗体の開発

抗体は、様々な科学分野の研究者がタンパク質の標的を特定、同定、局在化、定量化することを可能にする不可欠な研究ツールです。医療技術の進歩は、顧客の要望に応じてカスタマイズされた抗体を、より迅速かつ効率的に発見するためのサポートとなっています。抗体の発見にバイオインフォマティクスを統合することで、カスタム抗体研究の向上が促進されています。人工知能（AI）は、カスタム抗体の探索に不可欠な付加価値ツールとして台頭する可能性を秘めています。AIと機械学習（ML）アルゴリズムは、大規模なデータセットを解析し、抗体と抗原の相互作用を予測し、抗体の特性を最適化します。これらの技術はまた、デザイン、スクリーニング、リードの最適化、パターンの同定、結合親和性の予測、さらなる特性解析のための抗体候補の優先順位付けにも役立ちます。AIとMLの利用は、大規模な抗体スクリーニングデータの効率的な解析と解釈の必要性に加え、ビッグデータ解析ソリューションの利用可能性の増大とコンピューティングパワーの進歩によって推進されています。AIとML技術の統合は、抗体探索プロジェクトの成功率を向上させ、より効果的な治療用抗体の開発を促進する可能性を秘めています。

カスタムモノクローナル抗体の使用は、腫瘍学研究において魅力的な分野です。臨床試験のほとんどはウサギ由来のモノクローナル抗体を用いて行われています。例えば、ヒト化抗血管増殖内皮因子（ウサギmAb）である抗VEGFは、転移性結腸直腸がんや他の固形がんに対する効果を評価するため、現在臨床試験中です。同様に、抗VEGFは加齢黄斑変性の治療薬として臨床研究中です。ウサギ由来のモノクローナル抗体は、抗原結合部位の相補性決定領域（CDR）が大きいため、マウス由来のモノクローナル抗体よりも優れていることが証明されています。さらに、モノクローナル抗体は、より親和性の高いクローンを作製するために使用することができます。例えば、Creative Biolabs社では、遺伝子発現やペプチド合成から抗体の精製や標識に至るまで、様々なカスタムポリクローナル抗体やモノクローナル抗体の作製サービスを提供しています。したがって、カスタムモノクローナル抗体は、予測期間中、抗体探索市場において収益性の高い動向として浮上する可能性が高いです。

世界の抗体探索市場」は、抗体の種類、性質、サービス、エンドユーザー、地域に基づいて区分されます。

抗体タイプに基づく洞察

製品タイプに基づき、抗体探索市場はモノクローナル抗体、ポリクローナル抗体、その他に区分されます。モノクローナル抗体セグメントは2022年に大きな市場シェアを占めました。同セグメントは予測期間中に6.9%という高いCAGRを記録すると予測されています。

モノクローナル抗体（mAbs）は、健康な細胞を傷つけることなく疾患細胞と特異的に相互作用するように設計されています。がん治療は、モノクローナル抗体が使用される重要な応用分野の一つです。これらは広く受け入れられている生物製剤であり、予測期間中、製薬メーカーに高価値のビジネスチャンスをもたらすと期待されています。さらに、患者や医師の間では、mAb治療の応用に関する認識が特に高まっています。その結果、さまざまな適応症の治療薬としてブロックバスターmAbが承認され、予測期間中の抗体探索市場の成長が期待されます。アバスチン、ハーセプチン、レミケード、リツキサンなど複数の薬剤が、がん、関節リウマチ、クローン病、潰瘍性大腸炎などの適応症でFDAから承認されています。

エンドユーザーに基づく洞察

エンドユーザーに基づき、抗体探索市場は製薬・バイオテクノロジー企業、研究所、その他に区分されます。製薬・バイオテクノロジー企業セグメントは、2022年に最大の抗体探索市場シェアを占め、同セグメントは2022年～2030年に7.2%という高いCAGRを記録すると予測されています。

製薬・バイオテクノロジー企業は、特定の疾患に対する抗体を同定し、商業規模で生産する能力があるため、抗体探索プロセスの重要な部分を占めています。創薬や研究開発のための高特異性抗体への需要の高まり、プロテオミクスやゲノミクスの分野での研究の増加、新しいターゲットやアッセイを特定するための抗体へのニーズの高まり、がん、HIV/AIDS、免疫不全症、血液疾患などいくつかの治療分野における研究開発活動の活発化は、製薬会社やバイオテクノロジー企業における抗体探索製品、ソリューション、サービスの需要を促進する重要な要因となっています。

米国食品医薬品局、米国疾病管理予防センター、世界がん観測所、世界保健機関、経済協力開発機構、厚生労働省、食品医薬品安全省、バイオメディカル先端研究開発局（BARDA）などは、抗体探索市場調査報告書を作成する際に参照した関連情報源の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察
  • 抗体探索市場、地域別

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 抗体探索市場情勢

  • 世界のPEST分析

第5章 抗体探索市場- 主な市場力学

  • 抗体探索市場- 主な市場力学
  • 市場促進要因
    • 研究開発投資の増加
    • がん罹患率の上昇
  • 市場抑制要因
    • 生産コストの高さ
  • 市場機会
    • 発展途上地域におけるバイオテクノロジー産業の普及
  • 今後の動向
    • カスタム抗体の開発
  • 促進要因と抑制要因の影響

第6章 抗体探索市場：世界市場分析

  • 抗体探索市場の売上高、2022年～2030年
  • 抗体探索市場-地域別内訳、2022年～2030年

第7章 抗体探索市場分析-抗体タイプ別

  • モノクローナル抗体
  • ポリクローナル抗体
  • その他

第8章 抗体探索市場の分析-性質別

  • ヒトおよびヒト化抗体
  • キメラ
  • マウス

第9章 抗体探索市場の分析-サービス別

  • ファージディスプレイ
  • ハイブリドーマ
  • トランスジェニック動物
  • 酵母ディスプレイ
  • シングルセル

第10章 抗体探索市場の分析-エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 研究機関
  • その他

第11章 抗体探索市場- 地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他のアジア太平洋諸国
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • その他の中東・アフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他の中南米

第12章 抗体探索市場-業界情勢

  • 抗体探索市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第13章 企業プロファイル

  • Charles River Laboratories International Inc
  • Creative Biolabs Inc
  • Evotec SE
  • Bruker Cellular Analysis Inc
  • BioDuro LLC
  • Sartorius AG
  • Aragen Life Sciences Ltd
  • Twist Bioscience Corp
  • NanoCellect Biomedical Inc
  • Biocytogen Pharmaceuticals Beijing Co Ltd

第14章 付録

図表

List Of Tables

  • Table 1. Antibody Discovery Market Segmentation
  • Table 2. New Cancer Cases Worldwide, in 2020
  • Table 3. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 4. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 5. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 6. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 7. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 8. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 9. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 10. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 11. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 12. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 13. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 14. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 16. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 17. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 18. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 19. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 20. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 21. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 22. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 23. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 24. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 25. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 26. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 27. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 28. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 29. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 30. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 31. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 32. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 33. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 34. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 35. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 36. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 37. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 38. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 39. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 40. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 41. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 42. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 43. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 44. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 45. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 46. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 47. Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 48. Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 49. Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 50. Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 51. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 52. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 53. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 54. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 55. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 56. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 57. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 58. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 59. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 60. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 61. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 62. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 63. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 64. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 65. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 66. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 67. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 68. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 69. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 70. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 71. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 72. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 73. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 74. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 75. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 76. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 77. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 78. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 79. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 80. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 81. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 82. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 83. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 84. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 85. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 86. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 87. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 88. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 89. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 90. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 91. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 92. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 93. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 94. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 95. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 96. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 97. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 98. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 99. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 100. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 101. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 102. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 103. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 104. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 105. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 106. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 107. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 108. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 109. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 110. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 111. Recent Inorganic Growth Strategies in the Antibody Discovery Market
  • Table 112. Recent Organic Growth Strategies in the Antibody Discovery Market
  • Table 113. Glossary of Terms, Antibody Discovery Market

List Of Figures

  • Figure 1. Antibody Discovery Market Segmentation, by Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Antibody Discovery Market Revenue (US$ Million), 2022 - 2030
  • Figure 5. Antibody Discovery Market Breakdown by Geography, 2022 and 2030 (%)
  • Figure 6. Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
  • Figure 7. Monoclonal Antibodies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Polyclonal Antibodies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Others: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
  • Figure 11. Human and Humanized: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Chimeric: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Murine: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Antibody Discovery Market Share (%) - by Services (2022 and 2030)
  • Figure 15. Phage Display: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hybridoma: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Transgenic Animal: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Yeast Display: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Single Cell: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Antibody Discovery Market Share (%) - by End User (2022 and 2030)
  • Figure 21. Pharmaceutical and Biotechnology Companies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Research Laboratories: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 26. North America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 27. US: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Europe: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 33. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 38. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 39. Asia Pacific: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 40. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 41. Asia Pacific: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 42. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 43. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 44. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 45. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 46. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 47. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 48. Middle East & Africa: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 49. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 50. Middle East & Africa: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 51. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 52. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 53. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 54. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 55. South & Central America: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 56. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 57. South & Central America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 58. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 59. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 60. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 61. Growth Strategies in the Antibody Discovery Market
目次
Product Code: TIPRE00007411

The antibody discovery market size is projected to surge from US$ 2.94 billion in 2022 to US$ 4.92 billion by 2030; the market is estimated to record a CAGR of 6.7% during 2022-2030. The increasing investments in research & development and the rising incidence of cancer propel the antibody discovery market growth.

The expansion of biopharmaceutical industry, which is highly focused on biologics, results in a higher demand for antibody research services than before. Increased collaborations between industry players and academic institutions facilitate resource sharing and accelerated antibody discovery. The shift toward patient-centered drug development, emphasizing personalized medicine and patient preferences, boosts the antibody discovery market.

Continued technological advancements such as high-throughput screening, phage display, and next-generation sequencing have resulted in improved efficiency and speed of antibody discovery processes. Increased funding for research and development activities from government organizations and private companies also spurs antibody discovery initiatives. Monoclonal antibodies are gaining popularity in therapeutic applications due to their specificity and effectiveness in targeting specific antigens, resulting in increased demand for antibody research services. Therefore, the growing demand for antibody-based therapies and the preference for outsourcing are likely to have a significant impact on the antibody discovery market forecast in the next few years.

Rising Incidence of Cancer Drives the Antibody Discovery Market

As per the Global Cancer Observatory (GLOBOCAN) estimates published in 2020, there were 19.3 million cancer cases across the world. The number of cases was significantly high in the US, China, and India. The GLOBOCAN further estimates that cancer cases in India would reach ~2.08 million by 2040, representing a rise of 57.5% from 2020. Similarly, as per the World Health Organization (WHO) data published in February 2022, ~10 million people have died from cancer worldwide. As per a report by the American Cancer Society, ~16.9 million individuals with a history of cancer have been residing in the US since January 2019. By January 2030, the population of cancer survivors is estimated to reach 22.1 million, which can be primarily associated with the aging of the population. Lung, breast, colorectal, prostate, and breast are among the most commonly reported cancer types. The rising incidences of cancer have raised concerns worldwide. Below is the list of common cancer cases reported worldwide in 2020.

  • Table 1.New Cancer Cases Worldwide, in 2020

Sr. No.Cancer TypeNumber of Cases (Million)

1Stomach1.09

2Skin (non-melanoma)1.2

3Prostate1.41

4Colon and rectum1.93

5Lung2.21

6Breast2.26

Source: World Health Organization, February 2020

Cancer is now a lifestyle disease commonly seen among people with unhealthy eating habits and those who don't engage much in physical activities. The frequent consumption of alcohol and tobacco adds to the risk of developing this condition. Chronic infectious diseases in low- and middle-income countries can further aggravate the cancer risk factors. An upsurge in the incidence of cancer indicates the need for innovative cancer treatments. Monoclonal antibodies represent a promising class of targeted anticancer agents that enhance the natural ability of immune systems to suppress cancer cell activity and eliminate cancer cells. Antibody-drug conjugates (ADCs) have also shown promising results in cancer treatment. Further, progress in modern biotechnology allows researchers and companies to provide well-designed novel antibodies, paving the way for successful treatments of various types of cancer. Thus, the burgeoning incidence of different types of cancer boosts the antibody discovery market growth.

Market Trend

Developments for Custom Antibodies

Antibodies are indispensable research tools that enable researchers in various scientific fields to specify, identify, localize, and quantify their protein targets. Advancements in medical technologies provide support for faster and highly efficient discoveries of antibodies that are customized as per the customers' requirements. Integrating bioinformatics in the discovery of antibodies has triggered improvements in custom antibody research. Artificial intelligence (AI) has the potential to emerge as an essential, value addition tool in the discovery of custom antibodies. AI and machine learning (ML) algorithms analyze large data sets, predict antibody-antigen interactions, and optimize antibody properties. These techniques can also aid in design, screening, and lead optimization; identify patterns; predict binding affinities; and prioritize antibody candidates for further characterization. The use of AI and ML is driven by the growing availability of big data analytics solutions and advancements in computing power, in addition to the need to efficiently analyze and interpret large-scale antibody screening data. The integration of AI and ML technologies has the potential to improve the success rates of antibody discovery projects and facilitate the development of more effective therapeutic antibodies.

The use of custom monoclonal antibodies is an attractive area in oncology research. Most of the clinical trials are performed using monoclonal antibodies derived from rabbits. For instance, anti-VEGF, a humanized anti-vascular growth endothelial factor (rabbit mAb), is currently under clinical studies for the evaluation of its effects on metastatic colorectal cancer and other solid tumors. Likewise, anti-VEGF is under clinical studies to treat age-related macular degeneration. Monoclonal antibodies derived from rabbits are proven to be a superior alternative to mouse-derived monoclonal antibodies due to a larger complementarity-determining region (CDR) in the antigen-binding site. In addition, monoclonal antibodies can be used to produce higher affinity clones. For instance, Creative Biolabs offers various custom polyclonal and monoclonal antibody production services, from gene expression or peptide synthesis to antibody purification and labeling. Therefore, custom monoclonal antibodies are likely to emerge as a profitable trend in the antibody discovery market during the forecast period.

The "Global Antibody Discovery Market" is segmented on the basis of antibody type, nature, services, end user, and geography.

Antibody Type-Based Insights

Based on product type, the antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held a larger market share in 2022. The same segment is anticipated to register a higher CAGR of 6.9% during the forecast period.

Monoclonal antibodies (mAbs) are designed to interact specifically with diseased cells without harming healthy cells. Cancer therapy is one of the significant application areas wherein monoclonal antibodies are used. These are widely accepted biologics and are expected to present high-value opportunities to pharmaceutical manufacturers during the forecast period. Moreover, awareness about the applications of mAb therapies is increasing notably among patients and physicians. As a result, the approval of blockbuster mAbs for the treatment of various indications is expected to favor the antibody discovery market growth during the forecast period. Several drugs such as Avastin, Herceptin, Remicade, and Rituxan have been approved by the FDA for cancer, rheumatoid arthritis, Crohn's disease, ulcerative colitis, etc.

End User-Based Insights

Based on end users, the antibody discovery market is segmented into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest antibody discovery market share in 2022, and the same segment is anticipated to register a higher CAGR of 7.2% during 2022-2030.

Pharmaceutical and biotechnology companies account for a significant part of the antibody discovery process because of their capabilities to identify antibodies for any specific disease and produce them on commercial scales. The elevating demand for high-specificity antibodies for drug discovery and development; growing research in the areas of proteomics and genomics; increasing need for antibodies for identifying new targets and assays; and rising R&D activities in several therapeutic areas such as cancer, HIV/AIDS, immunodeficiency diseases, and blood disorders are the critical factors driving the demand for antibody discovery products, solutions, and services in pharmaceutical and biotechnology companies.

US Food and Drug Administration, Centers for Disease Control and Prevention, Global Cancer Observatory, World Health Organization, Organization for Economic Co-operation and Development, Ministry of Health, Labour and Welfare, Ministry of Food and Drug Safety, Biomedical Advanced Research and Development Authority (BARDA) are some of the relevant sources referred while preparing the antibody discovery market research report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Antibody Discovery Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Antibody Discovery Market Landscape

  • 4.1 Overview
  • 4.2 Global PEST Analysis

5. Antibody Discovery Market - Key Market Dynamics

  • 5.1 Antibody Discovery Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Investments in Research & Development
    • 5.2.2 Rising Incidence of Cancer
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Production
  • 5.4 Market Opportunities
    • 5.4.1 Proliferation of Biotechnology Industry in Developing Regions
  • 5.5 Future Trends
    • 5.5.1 Developments for Custom Antibodies
  • 5.6 Impact of Drivers and Restraints:

6. Antibody Discovery Market - Global Market Analysis

  • 6.1 Antibody Discovery Market Revenue (US$ Million), 2022-2030
  • 6.2 Antibody Discovery Market- Breakdown by Geography, 2022-2030

7. Antibody Discovery Market Analysis - by Antibody Type

  • 7.1 Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Overview
    • 7.2.2 Monoclonal Antibodies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Polyclonal Antibodies
    • 7.3.1 Overview
    • 7.3.2 Polyclonal Antibodies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. Antibody Discovery Market Analysis - by Nature

  • 8.1 Overview
  • 8.2 Human and Humanized
    • 8.2.1 Overview
    • 8.2.2 Human and Humanized: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Chimeric
    • 8.3.1 Overview
    • 8.3.2 Chimeric: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Murine
    • 8.4.1 Overview
    • 8.4.2 Murine: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. Antibody Discovery Market Analysis - by Services

  • 9.1 Overview
  • 9.2 Phage Display
    • 9.2.1 Overview
    • 9.2.2 Phage Display: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Hybridoma
    • 9.3.1 Overview
    • 9.3.2 Hybridoma: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Transgenic Animal
    • 9.4.1 Overview
    • 9.4.2 Transgenic Animal: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Yeast Display
    • 9.5.1 Overview
    • 9.5.2 Yeast Display: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Single Cell
    • 9.6.1 Overview
    • 9.6.2 Single Cell: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. Antibody Discovery Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Pharmaceutical and Biotechnology Companies
    • 10.2.1 Overview
    • 10.2.2 Pharmaceutical and Biotechnology Companies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Research Laboratories
    • 10.3.1 Overview
    • 10.3.2 Research Laboratories: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

11. Antibody Discovery Market - Geographical Analysis

  • 11.1 North America Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.2.1 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.1.2.2 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.1.2.3 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.1.2.4 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.1.3 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.1.3.1 US
        • 11.1.3.1.1 Overview
        • 11.1.3.1.2 US: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.3.1.3 United States: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.1.3.1.4 United States: Antibody Discovery Market Breakdown, by Nature
        • 11.1.3.1.5 United States: Antibody Discovery Market Breakdown, by Services
        • 11.1.3.1.6 United States: Antibody Discovery Market Breakdown, by End User
      • 11.1.3.2 Canada
        • 11.1.3.2.1 Overview
        • 11.1.3.2.2 Canada: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.3.2.3 Canada: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.1.3.2.4 Canada: Antibody Discovery Market Breakdown, by Nature
        • 11.1.3.2.5 Canada: Antibody Discovery Market Breakdown, by Services
        • 11.1.3.2.6 Canada: Antibody Discovery Market Breakdown, by End User
      • 11.1.3.3 Mexico
        • 11.1.3.3.1 Overview
        • 11.1.3.3.2 Mexico: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.3.3.3 Mexico: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.1.3.3.4 Mexico: Antibody Discovery Market Breakdown, by Nature
        • 11.1.3.3.5 Mexico: Antibody Discovery Market Breakdown, by Services
        • 11.1.3.3.6 Mexico: Antibody Discovery Market Breakdown, by End User
  • 11.2 Europe Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.2.1 Overview
    • 11.2.2 Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.2.2.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.2.2.2 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.2.2.3 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.2.2.4 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.2.3 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.1 UK
        • 11.2.3.1.1 Overview
        • 11.2.3.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.1.4 UK: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.1.5 UK: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.1.6 UK: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.2 Germany
        • 11.2.3.2.1 Overview
        • 11.2.3.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.2.4 Germany: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.2.5 Germany: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.2.6 Germany: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.3 France
        • 11.2.3.3.1 Overview
        • 11.2.3.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.3.4 France: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.3.5 France: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.3.6 France: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.4 Italy
        • 11.2.3.4.1 Overview
        • 11.2.3.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.4.4 Italy: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.4.5 Italy: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.4.6 Italy: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.5 Spain
        • 11.2.3.5.1 Overview
        • 11.2.3.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.5.4 Spain: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.5.5 Spain: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.5.6 Spain: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.6 Rest of Europe
        • 11.2.3.6.1 Overview
        • 11.2.3.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User
  • 11.3 Asia Pacific Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.3.2.1 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.3.2.2 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.3.2.3 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.3.2.4 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.3.3 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.1 China
        • 11.3.3.1.1 Overview
        • 11.3.3.1.2 China: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.1.3 China: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.1.4 China: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.1.5 China: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.1.6 China: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.2 Japan
        • 11.3.3.2.1 Overview
        • 11.3.3.2.2 Japan: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.2.3 Japan: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.2.4 Japan: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.2.5 Japan: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.2.6 Japan: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.3 India
        • 11.3.3.3.1 Overview
        • 11.3.3.3.2 India: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.3.3 India: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.3.4 India: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.3.5 India: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.3.6 India: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.4 Australia
        • 11.3.3.4.1 Overview
        • 11.3.3.4.2 Australia: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.4.3 Australia: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.4.4 Australia: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.4.5 Australia: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.4.6 Australia: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.5 South Korea
        • 11.3.3.5.1 Overview
        • 11.3.3.5.2 South Korea: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.5.3 South Korea: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.5.4 South Korea: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.5.5 South Korea: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.5.6 South Korea: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.6 Rest of APAC
        • 11.3.3.6.1 Overview
        • 11.3.3.6.2 Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.6.3 Rest of APAC: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.6.4 Rest of APAC: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.6.5 Rest of APAC: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.6.6 Rest of APAC: Antibody Discovery Market Breakdown, by End User
  • 11.4 Middle East & Africa Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.4.2.1 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.4.2.2 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.4.2.3 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.4.2.4 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.4.3 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 Saudi Arabia
        • 11.4.3.1.1 Overview
        • 11.4.3.1.2 Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.1.3 Saudi Arabia: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.4.3.1.4 Saudi Arabia: Antibody Discovery Market Breakdown, by Nature
        • 11.4.3.1.5 Saudi Arabia: Antibody Discovery Market Breakdown, by Services
        • 11.4.3.1.6 Saudi Arabia: Antibody Discovery Market Breakdown, by End User
      • 11.4.3.2 South Africa
        • 11.4.3.2.1 Overview
        • 11.4.3.2.2 South Africa: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.2.3 South Africa: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.4.3.2.4 South Africa: Antibody Discovery Market Breakdown, by Nature
        • 11.4.3.2.5 South Africa: Antibody Discovery Market Breakdown, by Services
        • 11.4.3.2.6 South Africa: Antibody Discovery Market Breakdown, by End User
      • 11.4.3.3 UAE
        • 11.4.3.3.1 Overview
        • 11.4.3.3.2 UAE: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.3.3 UAE: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.4.3.3.4 UAE: Antibody Discovery Market Breakdown, by Nature
        • 11.4.3.3.5 UAE: Antibody Discovery Market Breakdown, by Services
        • 11.4.3.3.6 UAE: Antibody Discovery Market Breakdown, by End User
      • 11.4.3.4 Rest of Middle East & Africa
        • 11.4.3.4.1 Overview
        • 11.4.3.4.2 Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.4.3 Rest of Middle East & Africa: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.4.3.4.4 Rest of Middle East & Africa: Antibody Discovery Market Breakdown, by Nature
        • 11.4.3.4.5 Rest of Middle East & Africa: Antibody Discovery Market Breakdown, by Services
        • 11.4.3.4.6 Rest of Middle East & Africa: Antibody Discovery Market Breakdown, by End User
  • 11.5 South & Central America Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.5.2.1 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.5.2.2 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.5.2.3 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.5.2.4 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.5.3 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Brazil
        • 11.5.3.1.1 Overview
        • 11.5.3.1.2 Brazil: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.1.3 Brazil: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.5.3.1.4 Brazil: Antibody Discovery Market Breakdown, by Nature
        • 11.5.3.1.5 Brazil: Antibody Discovery Market Breakdown, by Services
        • 11.5.3.1.6 Brazil: Antibody Discovery Market Breakdown, by End User
      • 11.5.3.2 Argentina
        • 11.5.3.2.1 Overview
        • 11.5.3.2.2 Argentina: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.2.3 Argentina: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.5.3.2.4 Argentina: Antibody Discovery Market Breakdown, by Nature
        • 11.5.3.2.5 Argentina: Antibody Discovery Market Breakdown, by Services
        • 11.5.3.2.6 Argentina: Antibody Discovery Market Breakdown, by End User
      • 11.5.3.3 Rest of South & Central America
        • 11.5.3.3.1 Overview
        • 11.5.3.3.2 Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.3.3 Rest of South & Central America: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.5.3.3.4 Rest of South & Central America: Antibody Discovery Market Breakdown, by Nature
        • 11.5.3.3.5 Rest of South & Central America: Antibody Discovery Market Breakdown, by Services
        • 11.5.3.3.6 Rest of South & Central America: Antibody Discovery Market Breakdown, by End User

12. Antibody Discovery Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Antibody Discovery Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Charles River Laboratories International Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Creative Biolabs Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Evotec SE
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Bruker Cellular Analysis Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 BioDuro LLC
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Sartorius AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Aragen Life Sciences Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Twist Bioscience Corp
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 NanoCellect Biomedical Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Biocytogen Pharmaceuticals Beijing Co Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms